Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review
- PMID: 21132551
- DOI: 10.1007/s00296-010-1650-8
Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review
Abstract
Patients with systemic onset juvenile idiopathic arthritis (SoJIA) are rarely known to develop coronary artery dilatation. The American heart association (AHA) statement on evaluation of suspected Kawasaki disease (KD) would lead some SoJIA patients (particularly in the early stages of the disease) to be inaccurately classified as KD. In addition to the institution of inappropriate therapy with IVIG, misdiagnosis as KD can delay definitive treatment for these SoJIA patients who probably have a worse predicted outcome. We present a 6-year-old male patient with SoJIA who was initially classified as incomplete KD. The child developed life-threatening macrophage activation syndrome (MAS). Previous literature regarding coronary dilatation in SoJIA is also reviewed.
Similar articles
-
A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.Pediatr Rheumatol Online J. 2024 Jan 2;22(1):4. doi: 10.1186/s12969-023-00944-2. Pediatr Rheumatol Online J. 2024. PMID: 38166957 Free PMC article. Review.
-
Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease.Turk J Pediatr. 2015 Sep-Oct;57(5):518-21. Turk J Pediatr. 2015. PMID: 27411422
-
Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease.J Pediatr. 2015 May;166(5):1283-8. doi: 10.1016/j.jpeds.2015.02.003. Epub 2015 Mar 11. J Pediatr. 2015. PMID: 25771391
-
Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.Clin Exp Immunol. 2018 Mar;191(3):349-355. doi: 10.1111/cei.13026. Epub 2017 Sep 15. Clin Exp Immunol. 2018. PMID: 28815559 Free PMC article.
-
Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.Rheumatol Int. 2023 Jan;43(1):183-189. doi: 10.1007/s00296-022-05231-z. Epub 2022 Oct 20. Rheumatol Int. 2023. PMID: 36264324 Review.
Cited by
-
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.BMJ Case Rep. 2019 Aug 4;12(8):e229708. doi: 10.1136/bcr-2019-229708. BMJ Case Rep. 2019. PMID: 31383678 Free PMC article.
-
A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.Pediatr Rheumatol Online J. 2024 Jan 2;22(1):4. doi: 10.1186/s12969-023-00944-2. Pediatr Rheumatol Online J. 2024. PMID: 38166957 Free PMC article. Review.
-
Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.Front Med (Lausanne). 2021 Nov 30;8:738850. doi: 10.3389/fmed.2021.738850. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34917629 Free PMC article. Review.
-
Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.BMC Med. 2012 Oct 23;10:125. doi: 10.1186/1741-7015-10-125. BMC Med. 2012. PMID: 23092393 Free PMC article.
-
Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children.Reumatologia. 2023;61(1):63-70. doi: 10.5114/reum/161185. Epub 2023 Mar 8. Reumatologia. 2023. PMID: 36998579 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical